This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based venture capital firm EnterprisePartners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Complete Genomics is developing a DNA sequencing product which competes against products from Illumina.
San Diego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. Celladon is backed by EnterprisePartners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others.
Carlsbad-based Breach Security , a developer of IT security tools, announced this morning that it has raised $5M in additional funding, from existing investor Sid R. The firm said the expansion financing would go towards product development and further market expansion. 5, or Evergreen Venture Partners participated in this round.
San Diego-based Celladon , a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said today. and Venrock. and Venrock. READ MORE>>.
San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. XIFIN''s investors include Boulder Ventures, EnterprisePartners, and Windward Ventures.
Vista-based Opthonix , a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M Opthonix is venture backed by Cross Creek Capital, DAG Ventures, EnterprisePartners, Gund Investment Corp., financing, according to a regulatory filing from the firm earlier this week.
San Diego-based ecoATM , a developer of automated kiosks for recycling cell phones and other electronics, said this morning that it has raised a first institutional round of funding. The round came from TAO Venture Partners, the new venture firm run by Tom Clancy. Clancy was previously managing director at EnterprisePartners.
San Diego- and Cupertino-based ParAccel , a developer of software for massively parallel databases used for data warehousing analytics, announced today that it has raised $22M in a venture capital round. ParAccel said the funding will go towards product development, sales and marketing, and to ramp up services and support.
San Diego-based XIFIN , a developer of revenue cycle management software-as-a-service for the healthcare industry, said Monday that it has named Craig Kussman as Chief Financial Officer at the firm. Kussman has previously served at Breach Security, Ascenta Therapeutics, Discovery Partners International, Inc., SYNAVANT Inc.,
San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. XIFIN''s backers include Boulder Ventures, EnterprisePartners, and Windward Ventures. Financial terms of the buy were not disclosed. GTCR said the investment came from its $3.85
San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M. The firm was advised by Peter J.
La Jolla-based Celladon Corporation , a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. Celladon is developing a compound for treating heart failure.
Santa Barbara-based AxiaMed , which is developing healthcare payments technology, said late Tuesday afternoon that it has raised $12.4M The funding was led by Health EnterprisePartners (HEP), and also included Nashville Capital Network and other existing investors. in a funding round.
Thousand Oaks-based Xirrus , the developer of Wi-Fi access arrays, looks to be a big channel expansion push, saying Thursday that it has expanded its partnership program in Europe, for the enterprise, as well as for schools and universities. Concurrently, the firm said it launched a new enterprisepartner program in the U.S.,
San Diego- and Baltimore-based private equity investor JMI Equity is the lead backer of a developer of artificial intelligence software for the healthcare industry this morning. The funding was led by JMI Equity, and also included Health EnterprisePartners (HEP) and Health Velocity Capital (HVC). READ MORE>>.
San Diego-based ParAccel, which develops database appliances used to accelerate database queries, said today that it has doubled its workforce over the past year, and has moved into new offices.
La Jolla-based Celladon , a developer of treatments for heart failure and other cardiovascular diseases, has raised $21.8M The firm now lists EnterprisePartners, Venrock, and Johnson & Johnson Development Corporation as investors in the company. out of a $24.6M
Solana Beach-based Wildfire Systems, which develops technology used for powering reward and loyalty programs, has raised $15M in a Series A funding, according to the company. Wildfire is led by founder and CEO Jordan Glazier, who is a technology vet, having served at eBay and also been the CEO of Eventful.
PricewaterhouseCoopers/National Venture Capital Association, and VentureOne will release their quarterly nationwide results of venture activity later this month.
Irvine-based Quartics, which is developing semiconductors for media processing, said Monday that it has named former AMD Executive Vice President Mario Rivas as the firm's new CEO. Quartics is backed by EnterprisePartners, Foundation Capital, and others. READ MORE>>
San Diego-based Scoperta , which is developing fabless specialty steel technology utilizing scrap materials, has raised $1.4M Other details on the funding have not been released, however, the firm is backed by EnterprisePartners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors.
Vista-based Ophthonix , which is developing high definition vision correction products, announced Tuesday afternoon that it has raised $25.9M Ophthonix develops the iZon lens system, which uses mapping of a person's visual aberrations to customize their eyeglass lenses for better visual acuity.
Quartics has previously raised capital from EnterprisePartners, Focus Ventures, Foundation Capital, Globespan Capital Partners, and Integral Capital Partners. Quartics is developing chips which provide media co-processing, including encoding and decoding video and other related functions.
Co-founder and EVP Terry Ash is now in charge of partner alliances, and the firm has hired on Dan Charleston as SVP of Business Development. The company is venture backed by ATA Ventures, EnterprisePartners, JK&B Capital, and Mission Ventures. READ MORE>>
It''s the same as a software company, which might take a lot of time and investment to develop a software program, and then license it on a per-seat basis to their enterprisepartners. As such, they pay us an upfront fee of $40,000 per store, and they pay us a half a percent royalty on gross sales.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content